The Medical Lifting Sling Market is Estimated to Grow at a CAGR of 11.4% to Reach USD 706.0 Million by 2020

Dublin, Sept. 07, 2015 (GLOBE NEWSWIRE) — Research and Markets (http://www.researchandmarkets.com/research/drz9zl/medical_lifting) has announced the addition of the “Medical Lifting Sling Market by Product (Transfer, Hammock, Toilet, Seating, Universal, Standing, Bariatric), by Material (Nylon, Padded, Canvas), by Usage Type (Disposable, Reusable), End User (Home, Hospital, Elderly) -Forecast to 2020” report to their offering.

The medical lifting sling market is expected to grow at a double-digit CAGR of 11.4% to reach USD 706.0 Million by 2020.

The medical lifting sling market by region is segmented into North America, Europe, Asia-Pacific and Row.

Factors such as the rise in geriatric population requiring assistance, increasing disabilities resulting from various lifestyle diseases such as diabetes and cardiovascular disease (CVD), government policies promoting the use of lifting slings, and high recovery cost of injuries are driving the growth of this market. However, lack of skilled training and knowledge to handle patients and persistent difficulty in handling obese patients are the key factors limiting the growth of this market.

Scope of the Report

– This report covers the global and regional market for medical slings market on the basis of products, usage type, material, and end user
– The market study does not cover the medical lifting slings market in terms of volume

Market Segmentation

This research report categorizes the medical lifting sling market on the basis of product, usage type, material, end user and region.

Medical Lifting Slings Market, by Usage Type

– Reusable Slings
– Disposable Slings

Medical Lifting Slings Market, by Product

– Universal Slings
– Transfer Slings
– Hammock Slings
– Standing Slings
– Seating Slings
– Toilet Slings
– Bariatric Slings
– Others (Positioning Slings and Pivot Slings)

Medical Lifting Slings Market, by Material

– Nylon
– Padded
– Mesh
– Canvas
– Others (Polypropylene and Cotton)

Medical Lifting Slings Market, by End User

– Home Care Facilities
– Hospitals
– Elderly Care Facilities
– Other End Users (Emergency Medical Services, Long-term Acute Care Facilities, Trauma Centers, and Nursing Homes)

Companies Mentioned

– ETAC AB
– Getinge Group (Arjohuntleigh)
– Guldmann Inc.
– Handicare as
– Hill-Rom Holdings, Inc.
– Invacare Corporation
– Joerns Healthcare, LLC
– Prism Medical Ltd.
– Silvalea Ltd.
– Spectra Care Group

For more information visit http://www.researchandmarkets.com/research/drz9zl/medical_lifting

CONTACT: 


CONTACT: Research and Markets
         Laura Wood, Senior Manager
         press@researchandmarkets.com

         For E.S.T Office Hours Call 1-917-300-0470
         For U.S./CAN Toll Free Call 1-800-526-8630
         For GMT Office Hours Call +353-1-416-8900

         U.S. Fax: 646-607-1907
         Fax (outside U.S.): +353-1-481-1716

         Sector: Medical Devices

Ads

You May Also Like

IASLC邀请肺癌专业人士参与全球分子诊断调查

胸部恶性肿瘤界的全球领袖开展调查,以评估如何改善全球分子诊断丹佛, July 13, 2018 (GLOBE NEWSWIRE) -- 国际肺癌研究协会(IASLC)鼓励所有参与肺癌患者分子诊断的人员参加一项全球调查,本调查旨在评估最佳实务的实施情况及最终制定分子诊断的全球指南。欲参加IASLC肺癌分子诊断全球调查,请访问www.iaslc.org/survey。 IASLC的医学博士、哲学博士和首席执行官Fred R. Hirsch表示,“肺癌科学的发展速度非常快。”Hirsch博士也指出,“为了确保患者护理跟上科学的发展,我们需要了解实施及采用新疗法的障碍。在收集、利用和传播数据以改变患者治疗效果方面,IASLC拥有独特的优势。” 许多指南建议在拥有腺癌组织学成分的晚期非小细胞肺癌(NSCLC)中测试致瘤分子驱动因子,例如EGFR、ROS1、ALK和BRAF。针对这些特定致癌分子驱动因子的疗法可以使患者延年益寿,但是在开始治疗之前需要知道是否存在驱动因子。 为了解肺癌分子诊断的现状以及任何区域性挑战和实施障碍,包括为什么并非所有地区均参与分子诊断,专家参与本调查至关重要。IASLC邀请医疗保健专业人员和其他利益相关方参与本调查。本调查提供英语、中文、日语、葡萄牙语和西班牙语版本。 肺癌分子诊断的IASLC全球调查结果将1)确定分子诊断的现状,2)揭露任何区域实施挑战或障碍,及3)为制定未来策略提供相关信息,以克服向全球肺癌患者普及分子诊断的障碍。主要发现摘要将与受访者分享,并且完整报告将会提交至IASLC官方期刊Journal ...